2CG Stock Overview
A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
NanoSphere Health Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.012 |
| 52 Week High | CA$0.029 |
| 52 Week Low | CA$0.0005 |
| Beta | -0.054 |
| 1 Month Change | 33.33% |
| 3 Month Change | 0% |
| 1 Year Change | 2,300.00% |
| 3 Year Change | -94.78% |
| 5 Year Change | -99.63% |
| Change since IPO | -99.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2CG | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 4.9% | -0.4% |
| 1Y | 2,300.0% | -19.9% | 4.2% |
Return vs Industry: 2CG exceeded the German Pharmaceuticals industry which returned -17.7% over the past year.
Return vs Market: 2CG exceeded the German Market which returned 5.4% over the past year.
Price Volatility
| 2CG volatility | |
|---|---|
| 2CG Average Weekly Movement | 333.7% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 2CG's share price has been volatile over the past 3 months.
Volatility Over Time: 2CG's weekly volatility has decreased from 1189% to 356% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | n/a | www.nanospherehealth.com |
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. NanoSphere Health Sciences Inc. was incorporated in 2005 and is headquartered in Vancouver, Canada.
NanoSphere Health Sciences Inc. Fundamentals Summary
| 2CG fundamental statistics | |
|---|---|
| Market cap | €173.60k |
| Earnings (TTM) | -€209.81k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.8x
P/E RatioIs 2CG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2CG income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$228.13k |
| Earnings | -US$228.13k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.022 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did 2CG perform over the long term?
See historical performance and comparison